Buscar
Mostrando ítems 1-9 de 9
Venous thromboembolism in heart transplant recipients: Incidence, recurrence and predisposing factors
(Elsevier para International Society for Heart and Lung Transplantation, 2015-10-02)
[Abstract] Background. A high frequency of venous thromboembolism (VTE) has been observed after lung, kidney, and liver transplantation. However, data about the incidence of this complication among heart transplant (HT) ...
Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results
(Wiley, 2015-04-23)
[Abstract] We conducted an observational study of 30 heart transplant recipients with serum low-density lipoprotein cholesterol (LDL-c) >100 mg/dl despite previous statin therapy, who were treated with rosuvastatin 10 mg ...
In-hospital postoperative infection after heart transplantation: risk factors and development of a novel predictive score
(Wiley, 2019-05-11)
[Abstract] Introduction: Infection is one of the most significant complications following heart transplantation (HT). The aim of this study was to identify specific risk factors for early postoperative infections in HT ...
Circulating miR-181a-5p as a New Biomarker for Acute Cellular Rejection in Heart Transplantation
(Elsevier, 2020-06-07)
[Abstract] Background: Acute cellular rejection (ACR) is a major complication in heart transplantation (HTx). Endomyocardial biopsy is the reference method for early detection of ACR, but a new non-invasive approach is ...
Usefulness of the INTERMACS scale for predicting outcomes after urgent heart transplantation
(Elsevier, 2011)
[Abstract] Introduction and objectives. Our aim was to assess the prognostic value of the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) scale in patients undergoing urgent heart transplantation ...
Chronic anemia in heart transplant patients: prevalence, risk factors, and prognostic significance
(Elsevier, 2007)
[Abstract] Introduction and objectives. Data on chronic anemia following heart transplantation (HT) are scarce and contradictory. Our aims were to determine the prevalence of chronic anemia after HT, to identify predisposing ...
Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection
(Elsevier, 2017-07-15)
[Abstract] Background. Heart transplantation (HT) is a life-saving treatment for patients with end-stage heart failure. One of the main problems after HT is the humoral response termed antibody-mediated rejection (AMR). ...
Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes
(Elsevier, 2023)
[Abstract] Purpose
To describe the evolution of the serum levels of soluble HLA-G (s-HLA-G) during the first 12 months after heart transplantation (HT) and to correlate it with clinical outcomes.
Methods
Observational ...
Epidemiological study of tricuspid regurgitation after cardiac transplantation: does it influence survival?
(Frontiers, 2022-03-21)
[Abstract] Background: Tricuspid valve disease is the most frequent valvulopathy after heart transplantation (HTx). Evidence for the negative effect of post-transplant tricuspid regurgitation (TR) on survival is contradictory. ...